CARA - Cara Therapeutics GAAP EPS of -$0.63 misses by $0.11 revenue of $0.82M misses by $0.43M March, 01 2022 04:08 PM Cara Therapeutics Inc. Cara Therapeutics press release (NASDAQ:CARA): GAAP EPS of -$0.63 misses by $0.11. Revenue of $0.82M (-99.3% Y/Y) misses by $0.43M. Shares -5.5%. For further details see: Cara Therapeutics GAAP EPS of -$0.63 misses by $0.11, revenue of $0.82M misses by $0.43M